Trade Gilead ^GILD

Potomac Fund Management Inc. ADV Invests $1.79 Million in Gilead Sciences, Inc. (NASDAQ:GILD)

Centric Wealth Management Invests $1.47 Million in Gilead Sciences, Inc. (NASDAQ:GILD)

B. Metzler seel. Sohn & Co. AG Sells 30,906 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

AIA Group Ltd Buys 9,664 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc (GILD) Unveils Breakthrough in HIV Treatment

NORTHAMPTON, MA / ACCESS Newswire / April 1, 2025 / In 2006

Seven Mile Advisory Invests $246,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Meeder Asset Management Inc. Increases Position in Gilead Sciences, Inc. (NASDAQ:GILD)

HighPoint Advisor Group LLC Has $1.82 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

2,350 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by IPG Investment Advisors LLC

3,801 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by C M Bidwell & Associates Ltd.

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by O Shaughnessy Asset Management LLC

Clearbridge Investments LLC Reduces Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Summit Securities Group LLC Increases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Transamerica Financial Advisors Inc. Sells 1,685 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Intrust Bank NA Has $2.47 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Maridea Wealth Management LLC Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Orion Portfolio Solutions LLC

Financial Engines Advisors L.L.C. Invests $222,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Financial Engines Advisors L.L.C. Makes New $222,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

denkapparat Operations GmbH Invests $1.14 Million in Gilead Sciences, Inc. (NASDAQ:GILD)

New Age Alpha Advisors LLC Purchases New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Blair William & Co. IL Sells 8,040 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Modern Wealth Management LLC Has $550,000 Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NasdaqGS:GILD) Faces Shareholder Proposals As Stock Rises 5%

Slagle Financial LLC Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Pictet Asset Management Holding SA Has $296.75 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Norges Bank Invests $1.79 Billion in Gilead Sciences, Inc. (NASDAQ:GILD)

84,672 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by Caisse Des Depots ET Consignations

12,015 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by LM Advisors LLC

Elo Mutual Pension Insurance Co Trims Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

TrueMark Investments LLC Increases Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Haverford Trust Co Reduces Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Quantbot Technologies LP Invests $870,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Prudential Financial Inc. Sells 45,470 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

LPL Financial LLC Increases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Fox Run Management L.L.C. Acquires New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

BH3 mimetics augment cytotoxic T cell killing of acute myeloid leukemia via mitochondrial apoptotic mechanism

Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Recommendation of "Moderate Buy" by Analysts

Crowley Wealth Management Inc. Purchases Shares of 2,480 Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Vanguard Group Inc.

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Corebridge Financial Inc.

Blueprint Investment Partners LLC Raises Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial

Napatree Capital LLC Purchases 971 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Lessened by HUB Investment Partners LLC

KLP Kapitalforvaltning AS Acquires Shares of 754,608 Gilead Sciences, Inc. (NASDAQ:GILD)

Mizuho Securities USA LLC Has $10.91 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Pharmaceutical Stocks To Keep An Eye On - March 20th

ZEGA Investments LLC Buys Shares of 6,047 Gilead Sciences, Inc. (NASDAQ:GILD)

Summit Global Investments Acquires New Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

2,582 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Wayfinding Financial LLC

TD Private Client Wealth LLC Sells 4,004 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Fi3 FINANCIAL ADVISORS LLC Purchases Shares of 2,386 Gilead Sciences, Inc. (NASDAQ:GILD)

Sector Gamma AS Has $18.24 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Inc (GILD) Shares Up 1.14% on Mar 22

SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)

Gilead Sciences Inc (GILD) Recognized Among Top Five Most Just Biopharma Companies

Gilead Sciences Inc (GILD) Stock Price Up 0.52% on Mar 21

Insider Sell: Andrew Dickinson Sells Shares of Gilead Sciences Inc (GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Northwest & Ethical Investments L.P.

Nucleoside prodrugs for viral infections disclosed in Gilead patent | BioWorld

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics

FDA Approves Novartis Drug for Rare Kidney Disease Treatment - March 21, 2025 - Zacks.com

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy - March 21, 2025 - Zacks.com

Gilead Sciences (NASDAQ:GILD) Stock Price Down 3% - Should You Sell?

752 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by VSM Wealth Advisory LLC

North Forty Two & Co. Makes New $573,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Trillium Asset Management LLC Sells 10,464 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights - March 20, 2025 - Zacks.com

GILD Stock Down on Report of Cut in HIV Prevention Spending - March 20, 2025 - Zacks.com

Novartis Reports Updated Positive Data From Phase III SMA Program - March 20, 2025 - Zacks.com

IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success - March 20, 2025 - Zacks.com

Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights | Valuespectrum.com

Company News for Mar 20, 2025 - March 20, 2025 - Zacks.com

Why Gilead Sciences (GILD) Is Among the Most Undervalued Biotech Stocks to Invest In

Gilead Sciences on Pace for Largest Percent Decrease Since November 2024 - Data Talk | Morningstar

Gilead Sciences Stock Price Down on Report HHS to Cut HIV Budget - Markets Insider

Advisors Asset Management Inc. Sells 29,260 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Thrivent Financial for Lutherans Sells 1,000,775 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Royce & Associates LP Sells 10,000 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Buy 3 U.S. Giants Flying High Year to Date Defying Severe Volatility - March 19, 2025 - Zacks.com

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review - March 19, 2025 - Zacks.com

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3

Cozad Asset Management Inc. Has $696,000 Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

NORTHAMPTON, MA / ACCESS Newswire / March 18, 2025 / We're p

Yearly HIV prevention injection shows promise in clinical trial - The Hindu

GWN Securities Inc. Invests $285,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Parallel Advisors LLC Reduces Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

2,569 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by SlateStone Wealth LLC

GWN Securities Inc. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

INCY Stock Down on Disappointing Skin Disease Study Data - March 18, 2025 - Zacks.com

D Andrew Dickinson - Insider Monkey

Gilead Sciences Inc. (GILD) - Insider Monkey

Is Gilead Sciences, Inc. (GILD) a Best Biotech Stock According to Billionaires?